Dr. Berne’s Eye Drops Recall Issued After FDA Contamination Warning
FDA sampling and testing has confirmed bacterial and fungal contamination in at least one lot of Dr. Berne’s recalled eye drops, which have been linked to adverse event reports
FDA sampling and testing has confirmed bacterial and fungal contamination in at least one lot of Dr. Berne’s recalled eye drops, which have been linked to adverse event reports
FDA sampling and testing found bacterial and fungal contamination in Dr. Berne's and LightEyez eye drops which could carry risks of vision loss and death.
Lawsuit indicates EzriCare eye drop infection occurred months after an Artificial Tears recall over Pseudomonas aeruginosa contamination.
Researchers linked the problem to a commercial water purifier added on to the hospital's water system.
This is the latest of a number of infant formula recalls announced in recent months following a massive Similac cronobacter recall last year which led to widespread illnesses and a formula shortage.
A new eye drops recall warns about the risk of bacterial contamination, infections and vision loss that may result from broken cap seals.
Recalled Artificial Eye Ointment carries the same risk of bacterial contamination that resulted in recent Artificial Tears eye drops recall, FDA warns.
Lawsuit alleges contaminated eye drops caused vision loss and surgery, joining a growing number of Artificial Tears lawsuits filed since a recall was announced due to bacterial contamination.
Lawsuit alleges contaminated eye drops caused a Pseudomonas aeruginosa infection and antibiotics did little to help fight off the treatment-resistant bacterial contamination
As a result of the Fabuloso infection risk, class action lawsuit seeks more than $5 million for consumers who paid a premium price for the recalled cleaning products